1. Home
  2. SLGL vs DXLG Comparison

SLGL vs DXLG Comparison

Compare SLGL & DXLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • DXLG
  • Stock Information
  • Founded
  • SLGL 1997
  • DXLG 1976
  • Country
  • SLGL Israel
  • DXLG United States
  • Employees
  • SLGL N/A
  • DXLG N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • DXLG Clothing/Shoe/Accessory Stores
  • Sector
  • SLGL Health Care
  • DXLG Consumer Discretionary
  • Exchange
  • SLGL Nasdaq
  • DXLG Nasdaq
  • Market Cap
  • SLGL 69.1M
  • DXLG 55.4M
  • IPO Year
  • SLGL 2018
  • DXLG 1987
  • Fundamental
  • Price
  • SLGL $33.66
  • DXLG $0.95
  • Analyst Decision
  • SLGL Strong Buy
  • DXLG Strong Buy
  • Analyst Count
  • SLGL 1
  • DXLG 1
  • Target Price
  • SLGL $50.00
  • DXLG $2.50
  • AVG Volume (30 Days)
  • SLGL 11.7K
  • DXLG 66.6K
  • Earning Date
  • SLGL 11-07-2025
  • DXLG 11-21-2025
  • Dividend Yield
  • SLGL N/A
  • DXLG N/A
  • EPS Growth
  • SLGL N/A
  • DXLG N/A
  • EPS
  • SLGL N/A
  • DXLG N/A
  • Revenue
  • SLGL $23,931,000.00
  • DXLG $447,744,000.00
  • Revenue This Year
  • SLGL N/A
  • DXLG N/A
  • Revenue Next Year
  • SLGL N/A
  • DXLG $3.95
  • P/E Ratio
  • SLGL N/A
  • DXLG N/A
  • Revenue Growth
  • SLGL 264.86
  • DXLG N/A
  • 52 Week Low
  • SLGL $4.01
  • DXLG $0.90
  • 52 Week High
  • SLGL $52.26
  • DXLG $3.10
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 45.02
  • DXLG 33.46
  • Support Level
  • SLGL $30.85
  • DXLG $0.91
  • Resistance Level
  • SLGL $39.00
  • DXLG $1.00
  • Average True Range (ATR)
  • SLGL 2.87
  • DXLG 0.06
  • MACD
  • SLGL -1.25
  • DXLG -0.00
  • Stochastic Oscillator
  • SLGL 22.17
  • DXLG 17.50

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About DXLG Destination XL Group Inc.

Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.

Share on Social Networks: